Aug 11, 2026 Earnings 8-K
Ambiq Micro reports Q2 2026 net sales up ~90% year-over-year to $33.9 million. GAAP gross profit rose 112.9% year-over-year to $15.3 million, with gross margin expanding 490 basis points to 45.0%.
Show details Hide details Net sales for Q2 2026 were $33.9 million, up 89.7% year-over-year from $17.9 million. GAAP net loss narrowed to $7.1 million from $8.5 million in the prior-year quarter. The company expects Q3 2026 net sales of $36.0 million to $37.0 million, representing the sixth consecutive quarter of sequential growth. Ambiq completed an upsized public offering in June, raising approximately $168 million in net proceeds. 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Jul 30, 2026 8-K
Ambiq Micro CEO letter marks first year as public company, raises $372M The company completed its IPO and two follow-on offerings, raising approximately $372 million in gross proceeds.
Show details Hide details Ambiq Micro, Inc. furnished a CEO letter dated July 30, 2026, reflecting on its first year as a public company. The letter highlights the SPOT platform, Apollo SoCs, and the new Atomiq family with integrated NPU. Approximately 80% of customers are integrating AI into their product designs. The letter was furnished under Item 7.01 Regulation FD Disclosure and is not considered filed for SEC purposes. 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
Jun 8, 2026 Shareholder vote 8-K
Ambiq Micro stockholders elect two Class I directors and ratify KPMG as auditor at 2026 annual meeting Stockholders elected Timothy Chen and Ker Zhang, Ph.D. as Class I directors, each to serve until the 2029 annual meeting.
Show details Hide details Ambiq Micro, Inc. held its 2026 Annual Meeting of Stockholders on June 8, 2026. Timothy Chen received 9,247,824 votes for and 1,931,909 withheld; Ker Zhang received 9,291,198 votes for and 1,888,535 withheld; broker non-votes were 2,701,784 for each. Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026, with 13,831,891 votes for, 11,022 against, and 38,604 abstentions. The report was filed under Item 5.07 to disclose the final voting results of the matters submitted to a vote of security holders. 5.07 Submission of Matters to a Vote of Security Holders
May 12, 2026 Earnings 8-K
Ambiq Micro reports Q1 2026 net sales of $25.1M, up 59.3% YoY, exceeding guidance. First quarter 2026 net sales were $25.06 million, a 59.3% increase year-over-year and 20.8% sequentially.
Show details Hide details GAAP gross margin was 43.5%; non-GAAP gross margin was 46.2%. GAAP net loss was $10.17 million; non-GAAP net loss was $5.05 million. Second quarter 2026 guidance: net sales of $31.0M to $32.0M, non-GAAP gross margin 45.0%-46.0%, non-GAAP net loss per share ($0.29)-($0.23). Top three customers accounted for ~71% of net sales in Q1 2026, down from 86% in Q1 2025. 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Mar 5, 2026 Earnings 8-K
Ambiq Micro reports Q4 2025 net sales of $20.7M, full year 2025 net sales of $72.5M Full year 2025 net sales were $72.5 million, down 4.7% from 2024, with sequential growth in every quarter.
Show details Hide details Fourth quarter 2025 net sales were $20.7 million, exceeding guidance and marking the highest quarterly net sales of 2025. Fourth quarter GAAP gross margin was 42.7%; non-GAAP gross margin was 45.5%. Full year 2025 GAAP net loss attributable to common stockholders was $36.5 million, or $4.57 per share. First quarter 2026 guidance: net sales of $21.0 million to $22.0 million, non-GAAP gross margin of 44.0% to 45.0%. 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Jan 21, 2026 Earnings 8-K
Ambiq Micro discloses preliminary 2025 net sales of $71.8M-$72.5M Gross profit estimated at $31.36M-$31.67M; gross margin 43.7%.
Show details Hide details Preliminary estimated net sales for year ended Dec 31, 2025: $71.77M-$72.47M. Net sales outside Mainland China estimated at $65.33M-$66.37M (91.0%-91.6% of net sales). Net sales in Mainland China estimated at $6.44M-$6.10M (9.0%-8.4% of net sales). Non-GAAP gross profit estimated at $31.79M-$32.30M; non-GAAP gross margin 44.3%-44.6%. 2.02 Results of Operations and Financial Condition
Jan 8, 2026 Leadership 8-K
Ambiq Micro expands board to seven, appoints Dr. Bernard B. Banks as Class III director Effective January 5, 2026, Ambiq Micro increased its board size from six to seven directors and appointed Dr. Bernard B. Banks to the new seat.
Show details Hide details Dr. Banks will serve as a Class III director until the 2028 annual meeting, when he is expected to stand for election. He was also appointed to the Audit Committee of the board. Dr. Banks is compensated under the company's Non-Employee Director Compensation Policy, same as other non-employee directors. He entered into an indemnification agreement with the company; no family relationships or reportable related-party transactions exist. 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Nov 6, 2025 Earnings 8-K
Ambiq Micro reports Q3 2025 net sales of $18.2M, guides Q4 to $18.5-$19.5M Third quarter 2025 net sales were $18.2 million, down 10.4% year-over-year but up 1.6% sequentially, exceeding guidance.
Show details Hide details GAAP gross margin was 42.3% and non-GAAP gross margin was 44.8%, reflecting a strategic shift to higher-value Edge AI customers. GAAP net loss attributable to common stockholders improved to $9.0 million ($0.72 per share) from $9.7 million in Q3 2024. Non-GAAP net loss attributable to common stockholders improved to $4.0 million ($0.22 per share pro forma) from $5.7 million in Q3 2024. Fourth quarter 2025 guidance: net sales of $18.5-$19.5 million and non-GAAP loss per share of ($0.44)-($0.34). 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
Show all 11 filings (3 more)